TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Navamedic ASA
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
531,436
|
511,997
|
382,135 |
| Financial expenses |
48,702
|
14,337
|
12,658 |
| Earnings before taxes |
-1,620
|
10,833
|
42,505 |
| Total assets |
467,477
|
524,305
|
382,772 |
| Current assets |
199,996
|
210,118
|
243,539 |
| Current liabilities |
140,818
|
189,283
|
126,061 |
| Equity capital |
216,673
|
222,392
|
209,720 |
| - share capital |
13,070
|
12,842
|
12,749 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
46.3%
|
42.4%
|
54.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.3%
|
2.1%
|
11.1% |
| Return on assets (ROA) |
10.1%
|
4.8%
|
14.4% |
| Current ratio |
142.0%
|
111.0%
|
193.2% |
| Return on equity (ROE) |
-0.7%
|
4.9%
|
20.3% |
| Change turnover |
19,439
|
129,862
|
103,696 |
| Change turnover % |
4%
|
34%
|
37% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.